scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.1080/08820130600745430 |
P698 | PubMed publication ID | 16916754 |
P50 | author | Kunle Odunsi | Q38296739 |
P2093 | author name string | Qing Chen | |
Sharon S Evans | |||
Joseph Skitzki | |||
Michelle M Appenheimer | |||
Wan-Chao Wang | |||
Daniel T Fisher | |||
P2860 | cites work | A Toll-like receptor recognizes bacterial DNA | Q24290668 |
Cancer immunotherapy: moving beyond current vaccines | Q24548229 | ||
Inflammation and cancer | Q24649640 | ||
ICAM-1 regulates neutrophil adhesion and transcellular migration of TNF-alpha-activated vascular endothelium under flow | Q24674849 | ||
Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes | Q24676216 | ||
Sub-lethal radiation enhances anti-tumor immunotherapy in a transgenic mouse model of pancreatic cancer | Q24793123 | ||
Integrin avidity regulation: are changes in affinity and conformation underemphasized? | Q28205914 | ||
High endothelial venules (HEVs): specialized endothelium for lymphocyte migration | Q28288508 | ||
Modulation of L-selectin ligand expression during an immune response accompanying tumorigenesis in transgenic mice | Q28770154 | ||
Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm | Q29547181 | ||
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival | Q29547865 | ||
Dissemination and growth of cancer cells in metastatic sites | Q29555846 | ||
Paradoxical roles of the immune system during cancer development | Q29614305 | ||
The immunobiology of cancer immunosurveillance and immunoediting | Q29616246 | ||
Smoldering and polarized inflammation in the initiation and promotion of malignant disease | Q29618034 | ||
Immunosuppressive networks in the tumour environment and their therapeutic relevance | Q29619244 | ||
Lymphocyte homing and homeostasis | Q29619924 | ||
Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer | Q29620068 | ||
IL-6 trans-signaling via STAT3 directs T cell infiltration in acute inflammation. | Q33892268 | ||
Innate control of adaptive immunity via remodeling of lymph node feed arteriole | Q34132263 | ||
Chemokines: immunology's high impact factors | Q34139595 | ||
Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer | Q34210036 | ||
Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells | Q34211233 | ||
Homing and cellular traffic in lymph nodes | Q34282818 | ||
An important role for granulocytes in the thermal regulation of colon tumor growth | Q34293611 | ||
Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules | Q34320910 | ||
Immunophenotype of lymphocytic infiltration in medullary carcinoma of the breast | Q34386128 | ||
Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. | Q34419957 | ||
Directing transition from innate to acquired immunity: defining a role for IL-6. | Q34449051 | ||
Chemokines in rapid leukocyte adhesion triggering and migration | Q34615498 | ||
Dissecting tumour pathophysiology using intravital microscopy | Q34632036 | ||
Spinning molecular immunology into successful immunotherapy | Q34632056 | ||
JAM-2, a novel immunoglobulin superfamily molecule, expressed by endothelial and lymphatic cells | Q34646874 | ||
Model predicting survival in stage I melanoma based on tumor progression | Q34669608 | ||
Endothelial activation: intracellular signaling pathways | Q34731148 | ||
Cytokine modified tumor vaccines | Q35027823 | ||
Rational approaches to human cancer immunotherapy | Q35044144 | ||
Hepatocyte growth factor suppresses vascular endothelial growth factor-induced expression of endothelial ICAM-1 and VCAM-1 by inhibiting the nuclear factor-kappaB pathway. | Q40473859 | ||
Tumor-associated macrophages: the double-edged sword in cancer progression. | Q40480669 | ||
Central role of IL-6 receptor signal-transducing chain gp130 in activation of L-selectin adhesion by fever-range thermal stress | Q40541651 | ||
Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration | Q40543299 | ||
Protocols for simulating the thermal component of fever: preclinical and clinical experience. | Q40545745 | ||
Cytokine and adhesion molecule expression in primary human endothelial cells stimulated with fever-range hyperthermia | Q40567151 | ||
A phase I study of fever-range whole body hyperthermia (FR-WBH) in patients with advanced solid tumours: correlation with mouse models | Q40581761 | ||
Fever-range hyperthermia dynamically regulates lymphocyte delivery to high endothelial venules | Q40604166 | ||
Fever-range hyperthermia stimulates alpha4beta7 integrin-dependent lymphocyte-endothelial adhesion | Q40626445 | ||
Contrasting frequencies of antitumor and anti-vaccine T cells in metastases of a melanoma patient vaccinated with a MAGE tumor antigen | Q41870799 | ||
Immune system and prognosis in colorectal cancer: a detailed immunohistochemical analysis | Q42457329 | ||
Strong expression of the lymphoattractant C-X-C chemokine Mig is associated with heavy infiltration of T cells in human malignant melanoma | Q42482085 | ||
Tumor necrosis factor-dependent segmental control of MIG expression by high endothelial venules in inflamed lymph nodes regulates monocyte recruitment | Q42947534 | ||
CpG-ODN-induced inflammation is sufficient to cause T-cell-mediated autoaggression against hepatocytes | Q43808151 | ||
JAM-1 is a ligand of the beta(2) integrin LFA-1 involved in transendothelial migration of leukocytes | Q43867713 | ||
Transformation of the microvascular system during multistage tumorigenesis | Q44575069 | ||
CXCR3/CXCR3 ligand biological axis impairs RENCA tumor growth by a mechanism of immunoangiostasis | Q46090369 | ||
Leukocyte function-associated antigen 1-mediated adhesion stability is dynamically regulated through affinity and valency during bond formation with intercellular adhesion molecule-1. | Q46350335 | ||
CpG motifs as proinflammatory factors render autochthonous tumors permissive for infiltration and destruction | Q47644730 | ||
Donor cell cycling, trafficking, and accumulation during adoptive immunotherapy for murine lung metastases | Q47937109 | ||
Tumor cell apoptosis, lymphocyte recruitment and tumor vascular changes are induced by low temperature, long duration (fever-like) whole body hyperthermia | Q50158515 | ||
Macrophage and mast-cell invasion of tumor cell islets confers a marked survival advantage in non-small-cell lung cancer. | Q50751212 | ||
Altered patterns of T cell migration through lymph nodes and skin following antigen challenge | Q52072356 | ||
Tumors as elusive targets of T-cell-based active immunotherapy | Q35155955 | ||
Tumor microvasculature as a barrier to antitumor immunity | Q35200590 | ||
Targeting T cell responses by selective chemokine receptor expression | Q35682772 | ||
Ligands for L-selectin: homing, inflammation, and beyond | Q35698423 | ||
Lymphocyte trafficking across high endothelial venules: dogmas and enigmas | Q35762431 | ||
Inflammation as a tumor promoter in cancer induction | Q35920466 | ||
Chemoattractants and their receptors in homeostasis and inflammation | Q35931538 | ||
IL-6 transsignaling: the in vivo consequences | Q36116485 | ||
Immunotherapy for pancreatic cancer - science driving clinical progress | Q36133140 | ||
Cancer vaccines: the challenge of developing an ideal tumor killing system | Q36170224 | ||
Dynamic control of lymphocyte trafficking by fever-range thermal stress | Q36207312 | ||
The cytoplasmic domain of L-selectin interacts with cytoskeletal proteins via alpha-actinin: receptor positioning in microvilli does not require interaction with alpha-actinin | Q36235670 | ||
Impact of fever-range thermal stress on lymphocyte-endothelial adhesion and lymphocyte trafficking | Q36246599 | ||
Inflammation-associated immune suppression in cancer: the roles played by cytokines, chemokines and additional mediators | Q36247789 | ||
Cytoplasmic anchorage of L-selectin controls leukocyte capture and rolling by increasing the mechanical stability of the selectin tether. | Q36294017 | ||
A transmigratory cup in leukocyte diapedesis both through individual vascular endothelial cells and between them | Q36322724 | ||
Thermal regulation of lymphocyte trafficking: hot spots of the immune response | Q36336648 | ||
Immune cell migration in inflammation: present and future therapeutic targets | Q36348737 | ||
Endothelial vascular cell adhesion molecule 1 expression is suppressed by melanoma and carcinoma | Q36364471 | ||
Migratory properties of naive, effector, and memory CD8(+) T cells | Q36369485 | ||
Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming | Q36371607 | ||
Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma | Q36375683 | ||
Inflammatory chemokine transport and presentation in HEV: a remote control mechanism for monocyte recruitment to lymph nodes in inflamed tissues | Q36376423 | ||
Coordinated redistribution of leukocyte LFA-1 and endothelial cell ICAM-1 accompany neutrophil transmigration | Q36399827 | ||
Reciprocal and dynamic control of CD8 T cell homing by dendritic cells from skin- and gut-associated lymphoid tissues | Q36402630 | ||
Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors | Q36402716 | ||
Human T cell responses against melanoma | Q36427328 | ||
Regulatory T cells, tumour immunity and immunotherapy | Q36430144 | ||
Role of cytokines in photodynamic therapy-induced local and systemic inflammation | Q36648974 | ||
Retrograde inflammatory signaling from neutrophils to endothelial cells by soluble interleukin-6 receptor alpha | Q37375605 | ||
Angiogenic profile of breast carcinoma determines leukocyte infiltration | Q38445307 | ||
Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor | Q40412166 | ||
Homing phenotypes of tumor-specific CD8 T cells are predetermined at the tumor site by crosspresenting APCs. | Q40455900 | ||
P433 | issue | 3-4 | |
P921 | main subject | immunotherapy | Q1427096 |
P304 | page(s) | 251-277 | |
P577 | publication date | 2006-01-01 | |
P1433 | published in | Immunological Investigations | Q15754982 |
P1476 | title | Hurdles to lymphocyte trafficking in the tumor microenvironment: implications for effective immunotherapy | |
P478 | volume | 35 |
Q37257207 | Adoptive T cell transfer for cancer immunotherapy in the era of synthetic biology |
Q36821063 | Anticancer DNA vaccine based on human telomerase reverse transcriptase generates a strong and specific T cell immune response |
Q36471557 | Blockade of Programmed Death 1 Augments the Ability of Human T Cells Engineered to Target NY-ESO-1 to Control Tumor Growth after Adoptive Transfer. |
Q41483538 | Chemoattractant Receptors BLT1 and CXCR3 Regulate Antitumor Immunity by Facilitating CD8+ T Cell Migration into Tumors. |
Q33925291 | Crosstalk between medulloblastoma cells and endothelium triggers a strong chemotactic signal recruiting T lymphocytes to the tumor microenvironment |
Q98237765 | Dynamic control of tumor vasculature improves antitumor responses in a regional model of melanoma |
Q43413284 | Endothelial plasticity governs the site-specific leukocyte recruitment in hepatocellular cancer |
Q92628342 | Ex vivo expanded patient-derived γδ T-cell immunotherapy enhances neuroblastoma tumor regression in a murine model |
Q38473933 | Expression of a functional CCR2 receptor enhances tumor localization and tumor eradication by retargeted human T cells expressing a mesothelin-specific chimeric antibody receptor |
Q37274068 | Expression of leukotriene B₄ receptor-1 on CD8⁺ T cells is required for their migration into tumors to elicit effective antitumor immunity |
Q55262681 | Future of anti-PD-1/PD-L1 applications: Combinations with other therapeutic regimens. |
Q38289029 | Going viral: chimeric antigen receptor T-cell therapy for hematological malignancies |
Q58746560 | ICAM-1-LFA-1 Dependent CD8+ T-Lymphocyte Aggregation in Tumor Tissue Prevents Recirculation to Draining Lymph Nodes |
Q35369944 | IL-6 trans-signaling licenses mouse and human tumor microvascular gateways for trafficking of cytotoxic T cells |
Q34989820 | Immune cells in the normal ovary and spontaneous ovarian tumors in the laying hen (Gallus domesticus) model of human ovarian cancer |
Q58731923 | Intra-arterial Versus Intravenous Adoptive Cell Therapy in a Mouse Tumor Model |
Q37229840 | Intravital imaging of CD8+ T cell function in cancer |
Q37967510 | Matrix metalloproteinases in cytotoxic lymphocytes impact on tumour infiltration and immunomodulation. |
Q38104594 | Positive and negative influence of the matrix architecture on antitumor immune surveillance |
Q30268502 | Potential immunotherapy targets in recurrent cervical cancer |
Q38122205 | Preconditioning thermal therapy: flipping the switch on IL-6 for anti-tumour immunity |
Q33495521 | Quantifying cellular interaction dynamics in 3D fluorescence microscopy data |
Q38284345 | Regulation of cytotoxic T-Lymphocyte trafficking to tumors by chemoattractants: implications for immunotherapy |
Q37576573 | Role of the Lymphotoxin/LIGHT System in the Development and Maintenance of Reticular Networks and Vasculature in Lymphoid Tissues |
Q45867420 | Synergy of adoptive T-cell therapy and intratumoral suicide gene therapy is mediated by host NK cells |
Q38068003 | T cell-based gene therapy of cancer |
Q37063499 | Targeted regulation of a lymphocyte-endothelial-interleukin-6 axis by thermal stress |
Q28073437 | The application of the fibroblast activation protein α-targeted immunotherapy strategy |
Q38268463 | The glioblastoma vasculature as a target for cancer therapy |
Q48892878 | Tracking the elusive lymphocyte: methods of detection during adoptive immunotherapy |
Q37597961 | Tumor-mediated inhibition of dendritic cell differentiation is mediated by down regulation of protein kinase C beta II expression |
Q36557847 | Tumour-infiltrating FOXP3(+) lymphocytes are associated with cytotoxic immune responses and good clinical outcome in oestrogen receptor-negative breast cancer. |
Q36038449 | What is the influence of vaccination's routes on the regression of tumors located at mucosal sites? |
Search more.